Metastatic pathways and time courses in the orderly progression of cutaneous melanoma

Summary Background  It is known that two‐thirds of patients who develop clinical metastases following treatment of a primary cutaneous melanoma initially present with locoregional metastases and one‐third initially present with distant metastases. However, few reports in the literature give detailed figures on different metastatic pathways in cutaneous melanoma.

[1]  M. Mihm,et al.  Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0 to 4.0 mm). Intergroup Melanoma Surgical Trial. , 2000, Annals of surgical oncology.

[2]  R. MacKie,et al.  Stage II melanoma in the west of Scotland, 1976-1985: prognostic factors for survival. , 1991, European journal of cancer.

[3]  C. Garbe,et al.  Primary cutaneous melanoma. Prognostic classification of anatomic location , 1995, Cancer.

[4]  A. Sober,et al.  Prognosis after initial recurrence of cutaneous melanoma. , 1991, Archives of surgery.

[5]  D. Coit,et al.  Prognosis of thick cutaneous melanoma of the trunk and extremity. , 1990, Archives of surgery.

[6]  C. Balch,et al.  Factors affecting survival following local, regional, or distant recurrence from localized melanoma , 1998, Journal of surgical oncology.

[7]  S. Singletary,et al.  Patterns of relapse in 1001 consecutive patients with melanoma nodal metastases. , 1989, Archives of surgery.

[8]  C. Garbe,et al.  [Position and recommendations of the Malignant Melanoma Committee of the German Society of Dermatology on diagnosis, treatment and after-care of malignant melanoma of the skin. Status 1993/94]. , 1994, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete.

[9]  C. Garbe,et al.  Stellungnahme und Empfehlungen der Kommission malignes Melanom der Deutschen Dermatologischen Gesellschaft zur Diagnostik, Behandlung und Nachsorge des malignen Melanoms der Haut , 1994, Der Hautarzt.

[10]  Martin F. Mihm,et al.  Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  M A Weinstock,et al.  Epidemiology of melanoma. , 2017, Cancer treatment and research.

[12]  H. Frydman,et al.  Malignant melanoma. Changing trends in factors influencing metastasis‐free survival from 1964 to 1982 , 1990, Cancer.

[13]  J. Elwood.  Recent developments in melanoma epidemiology, 1993. , 1993, Melanoma research.

[14]  M. Ross,et al.  Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  F. Meyskens,et al.  Cutaneous malignant melanoma. II. The natural history and prognostic factors influencing the development of stage II disease , 1989, Cancer.

[16]  N Cascinelli,et al.  Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  C. Balch,et al.  A Multifactorial Analysis of Melanoma: Prognostic Histopathological Features Comparing Clark's and Breslow's Staging Methods , 1978, Annals of surgery.

[18]  M. Ross,et al.  Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  U. Ringborg,et al.  The association between anatomic site and survival in malignant melanoma. An analysis of 12,353 cases from the Swedish Cancer Registry. , 1989, European journal of cancer & clinical oncology.

[20]  W. Clark,et al.  The histogenesis and biologic behavior of primary human malignant melanomas of the skin. , 1969, Cancer research.

[21]  D. Reintgen,et al.  Recurrent malignant melanoma: the identification of prognostic factors to predict survival. , 1992, Annals of plastic surgery.

[22]  C. Balch,et al.  Cutaneous melanoma: prognosis and treatment results worldwide. , 1992, Seminars in surgical oncology.

[23]  R. Dobson,et al.  British Association of Dermatologists , 2014 .

[24]  D. Coit,et al.  Axillary dissection in melanoma. Prognostic variables in node-positive patients. , 1990, Annals of surgery.

[25]  M. Mihm,et al.  Long-Term Results of a Multi-Institutional Randomized Trial Comparing Prognostic Factors and Surgical Results for Intermediate Thickness Melanomas (1.0 to 4.0 mm) , 2000, Annals of Surgical Oncology.

[26]  Elwood Jm.  Recent developments in melanoma epidemiology, 1993. , 1993 .

[27]  M. Skobe,et al.  Concurrent induction of lymphangiogenesis, angiogenesis, and macrophage recruitment by vascular endothelial growth factor-C in melanoma. , 2001, The American journal of pathology.